ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy
FRIDAY, July 18, 2025 -- An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July 12 to 15 in San Francisco.
Jansi Rani Sethuraj, R.N., from the University of Texas Health Science Center at Houston, and colleagues developed an AI-powered model integrated into the Simple Mobile AI Retina Tracker (SMART), a universally accessible application for detection, staging, and monitoring of diabetic retinopathy progression. Pretrained models from deep learning architectures were trained on anonymized fundoscopic images from diverse populations with diabetes. The trained models then underwent rigorous internal validation and external validation in multiple datasets. The ability of models to differentiate diabetic retinopathy from 39 ocular conditions was examined.
The researchers found that across diverse datasets, the EfficientNetB0 achieved more than 99 percent accuracy, with an image processing speed <1 second per image. The model demonstrated superior computational efficiency, with one-third runtime compared with ResNet18; across tested datasets, it maintained robust generalization (area under the receiver operating characteristic curve, >0.99). Real-world feasibility was confirmed in external evaluations.
"The SMART AI application enables ophthalmologists to streamline patient screening, empowers primary care providers to incorporate eye exams into routine visits, and expands access to high-quality retinal assessments in regions lacking specialized ophthalmic care," Sethuraj said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Elderly Patients Benefit From Screening Mammography
WEDNESDAY, Oct. 1, 2025 -- Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with earlier-stage disease and have better...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.